47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.1 - Rental and leasing of motor vehicles
77.3 - Rental and leasing of other machinery, equipment, and tangible assets
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,3 | 3,3 | |
Gross profit (loss) | 0,5 | 0,3 | 0,3 | -7,6 |
EBITDA | 0,5 | 0,3 | 0,3 | -7,3 |
Short time liabilities | 0,7 | 0,7 | 1,3 | 83,7 |
Other operating costs | 0 | 0 | -35,4 | |
Equity capital | 0,9 | 1 | 0,8 | -13,6 |
Operating profit (EBIT) | 0,5 | 0,3 | 0,3 | -4,9 |
Assets | 1,5 | 1,7 | 2,2 | 24,8 |
Net profit (loss) | 0,4 | 0,3 | 0,2 | -16,2 |
Cash | 0,3 | 0,2 | 0,3 | 33,4 |
Liabilities and provisions for liabilities | 0,7 | 0,8 | 1,3 | 73,9 |
Net income from sale | 8,6 | 10 | 11,2 | 11,2 |
Working assets | 1,5 | 1,7 | 2,2 | 25,7 |
Other income costs | 0 | 0 | -98,5 | |
Depreciation | 0 | 0 | 0 | -49,2 |
% | % | % | p.p. | |
Profitability of capital | 27,9 | 27,1 | -0,8 | |
Equity capital to total assets | 55,9 | 56,1 | 38,8 | -17,3 |
Gross profit margin | 5,7 | 3,2 | 2,6 | -0,6 |
EBITDA Margin | 5,9 | 3,4 | 2,8 | -0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 44 | 18 | |
Current financial liquidity indicator | 2.210256814956665 | 2.370546579360962 | 1.622698187828064 | -0,8 |
Net dept to EBITDA | -0.5496648550033569 | 0.6325789093971252 | 1,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane